United Kingdom· GB-APID-3762111000001105

Xepin 5% cream

A doxepin product containing doxepin, registered in United Kingdom by Cambridge Healthcare Supplies Ltd. The same ATC class is registered in 2 of our 19 countries.

ATC D04AX01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedXepin 5% creamATCD04AX01REGISTER NO.GB-APID-3762111000001…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Doxepin is registered in 2 of 19 countries.

Countries holding a registration under ATC D04AX01 (doxepin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 1 of them publish a price we can compare per daily dose

Doxepin · ATC D04AX01

2 / 19 countries

  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Doxepin
Manufacturer
Cambridge Healthcare Supplies Ltd
Country
United Kingdom (GB)
ATC code
D04AX01
ATC class
Doxepin
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5037336000133
  • gtin
    05037336000461

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

591 interactions on record for doxepin.

Graded by severity as the source publishes them — 127 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Doxepin · interactions on record

591 records

  • 127 severe
  • 448 moderate
  • 16 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Doxepin in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxepin products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Doxepin Al, Doxepin Ratiopharm
  • Spain · Sinequan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2876280b-33e6-42ed-9277-b637b37593c8
GET /v1/drugs/2876280b-33e6-42ed-9277-b637b37593c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3762111000001105",
  "desc": "Xepin 5% cream (Cambridge Healthcare Supplies Ltd)",
  "form": "Cutaneous cream",
  "vpid": "41896411000001108",
  "source": "dmd",
  "vtm_id": "775696004",
  "strength": "50 mg",
  "substance": "Doxepin",
  "ingredient": "Doxepin hydrochloride",
  "supplier_code": "3746001000001102"
}

See everything about doxepin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.